U.S. market Closed. Opens in 17 hours 1 minute

PHAT | Phathom Pharmaceuticals, Inc. Stock Financials Income Statements Annual

(Stock Exchange: NASDAQ)
*Sign In to persist settings
Financial Year End2023-12-312022-12-312021-12-312020-12-312019-12-312018-12-31
Revenue682.00KN/AN/AN/AN/AN/A
Cost of Revenue167.00K620.00K521.00K300.00K8.00KN/A
Gross Profit515.00K-620.00K-521.00K-300.00K-8.00KN/A
Operating Expenses167.83M172.44M135.08M125.67M106.22M1.23M
Selling, General & Admin117.93M101.00M62.74M27.52M6.94M1.21M
Research & Development49.90M71.44M72.34M98.15M99.27M20.00K
Other Operating Expenses-188.00K-110.00K-2.06M-8.00K-49.56M-50.00K
Operating Income-167.31M-172.44M-135.08M-125.67M-106.22M-1.23M
Other Expenses / Income-188.00K-25.28M-8.80M-3.40M-148.92M-50.00K
Before Tax Income-201.59M-197.72M-143.88M-129.07M-255.13M-1.29M
Income Tax Expenses41.78M25.28M4.21M4.25M-45.39M13.00K
Net Income-201.59M-223.01M-148.09M-133.32M-209.74M-1.29M
Interest Expenses41.97M27.30M6.79M4.58M4.18M13.00K
Basic Shares Outstanding51.29M39.12M37.00M33.23M24.73M8.58M
Diluted Shares Outstanding51.29M39.12M37.00M33.23M24.73M8.58M
EBITDA-159.05M-170.42M-137.09M-124.58M-154.68M-1.27M
EBITDA Margin-23,320.97%0.00%0.00%0.00%0.00%0.00%
EBIT-117.84M-170.42M-137.09M-124.49M-250.95M-1.26M
EBIT Margin-17,279.18%0.00%0.00%0.00%0.00%0.00%
Financial Year End2023-12-312022-12-312021-12-312020-12-312019-12-312018-12-31
An error has occurred. This application may no longer respond until reloaded. Reload 🗙